Glycerol tight market business investment continued to rise

ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
Triclosana href='https://www.echemi.com/products/pid_Seven3714-triclocarban.html'>Triclocarban.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
2026-10-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Is Glycerol Water Soluble? An Oddball Solution For Hydration
-
Market Analysis - Weekly Report - February 14th to February 18th, 2022- Hot Products
-
Market Analysis- Weekly Report- November 1st to November 5th, 2021- Hot Products
-
BASF sends out a price increase letter again! MDI, glycerol, epoxy and many other raw materials have soared!
-
BASF Moves to Sell 4,400 Employee Homes—Union Fury Reveals the Survival Math of a Chemical Giant
-
The Most Striking Thing in BASF’s 2025 Results Isn’t Profit — It’s “Cutting Weight” and “Stopping the Bleeding” at the Same Time
-
Wanhua Chemical Establishes a RMB 1.488 Billion New Energy Materials Company in Weifang, Further Integrating Green Power and Battery Materials Businesses
-
Soybeans Tread Water Amid Trade Whispers and Biofuel Hopes
-
Sinopec and CNAF to Implement Restructuring
-
Saudi Aramco Considers Selling Arlanxeo
Recommend Reading
-
The Carbon Neutrality Hidden in Adhesives: Henkel’s Acquisition of ATP Isn’t About Sticking Better—It’s About Moving Faster
-
Sichuan’s 120,000 Tons Approved, Shandong’s 500,000 Tons on the Way:Is Wanhua Chemical Set to “Break Through” the LFP Market?
-
Suave Brands and Elida Beauty Complete Merger to Form Personal Care Giant Evermark with Annual Retail Sales Near $1.9 Billion
-
Clariant and FUHUA Establish Joint Venture to Co-Develop Halogen-Free Flame Retardants
-
Akzo Nobel and Axalta Announce a $25 Billion Merger Deal
-
Business Society’s Market Outlook for Phthalic Anhydride on August 25, 2026: Strongly Bullish
-
Business Society September 20, 2026 DOP Trend Analysis: Clearly Downward
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
Business Society’s Market Outlook for Maleic Anhydride on August 24, 2026: Volatile
-
Business Society’s Lithium Carbonate Trend Analysis for September 20, 2026: Clearly Upward